NOMAD POWER SOLUTIONS, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NOMAD POWER SOLUTIONS, INC. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $53.40K.
- NOMAD POWER SOLUTIONS, INC. stock issued during period, value, issued for services for the quarter ending 2025-12-31 was $126.90K.
- NOMAD POWER SOLUTIONS, INC. stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $44.71K.
- NOMAD POWER SOLUTIONS, INC. stock issued during period, value, issued for services for fiscal 2025 was $171.61K.
- NOMAD POWER SOLUTIONS, INC. stock issued during period, value, issued for services for fiscal 2020 was $100.00K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-03-31 | $53.40K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $126.90K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $171.61K 10-K · filed 2026-03-31 |
| 2025-09-30 | $44.71K 10-Q · filed 2025-11-12 | |
| 2020-12-31 | $100.00K 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |